If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
158.20    1.00 (0.64%)
Bid:
157.60
Ask:
157.80
Spread: 0.20 (0.127%)
Market Cap: £903.28m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading update

14 Jan 2020 07:00

RNS Number : 6681Z
Elementis PLC
14 January 2020
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Elementis plc

14 January 2020

Trading Update

 

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues the following trading update in advance of its full year results for the 12 months to 31 December 2019, which are scheduled to be announced on 4 March 2020.

Business performance

Trading in the final quarter of the year has been somewhat subdued and as a result adjusted operating profit for 2019 is anticipated to be $122-124m.

·; Personal Care had a mixed end to the year with continued solid performance in cosmetics and ongoing competitive pressures in AP Actives.

 

·; In Coatings, demand conditions were in line with expectations and operating margins remained resilient supported by new business wins, cost savings delivery and price/mix improvements.

 

·; In Talc, performance was in line with expectations with solid industrial talc demand driven by good momentum in coatings and technical ceramics, more than offsetting continued demand weakness in long life plastics. Second half performance materially improved driven by new business, cost synergies and nickel sales phasing.

 

·; In Chromium, a weak demand environment and lower market prices resulted in weaker than expected performance. This was particularly acute in the rest of the world, whereas margins in North America have remained robust.

 

·; Energy performance was weaker than expected due to a further slowdown in North American drilling activity, with the Q4 rig count down approximately 25% on the prior year period.

 

 

Cash Conversion

In 2019, our operating cash conversion* is expected to be in line with our medium term performance objective of at least 90%. This has been driven by disciplined capital expenditure and sustainable working capital reduction. As a result, net debt for the year is anticipated to be approximately $465m, representing around 2.8x net debt to EBITDA**.

Financial deleveraging remains a key focus. The execution of our medium term innovation, growth and efficiency priorities combined with strong cash generation will drive a clear deleveraging profile.

Paul Waterman, CEO, said,

"Our overall performance in 2019 has been negatively impacted by a challenging market backdrop as the more cyclically exposed parts of the portfolio like Chromium and Energy have deteriorated through H2. However, as outlined at the recent Capital Markets Day, our priorities going forward are clear. We remain committed to delivering our medium term Group performance objectives of a 17% operating profit margin, operating cash conversion of at least 90% per annum and financial leverage of under 1.5x EBITDA, with further reduction thereafter."

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

 

Notes

*Defined as (Adjusted EBITDA - capex - working capital change) / adjusted operating profit

** Defined on a pre-IFRS16 basis

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGZGMMMFKGGZZ
Date   Source Headline
13th Nov 202011:11 amBUSForm 8.3 - Elementis Plc
13th Nov 202010:40 amPRNForm 8.3 - Elementis plc
13th Nov 20209:54 amRNSForm 8.5 (EPT/NON-RI) - Elementis plc
13th Nov 20209:51 amRNSForm 8.5 (EPT/RI) - Elementis plc
13th Nov 20209:47 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - ELEMENTIS PLC - Ordinary Shares
12th Nov 20209:39 amRNSResponse to Minerals Technologies Inc announcement
12th Nov 20207:51 amRNSStatement re Possible Offer
9th Nov 20204:55 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
26th Oct 20207:00 amRNSUpdate on 2020 AGM resolution vote
16th Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:40 pmRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSCovenant update
1st Sep 20202:22 pmRNSBlock listing Interim Review
28th Jul 20207:00 amRNSHalf-year Report
8th Jun 20204:28 pmRNSHolding(s) in Company
15th May 20201:08 pmRNSHolding(s) in Company
1st May 20209:56 amRNSTotal Voting Rights
29th Apr 202011:02 amRNSDirector Declaration
29th Apr 202010:49 amRNSResult of AGM
29th Apr 20207:00 amRNSAGM Trading Statement
28th Apr 202012:06 pmRNSDisclosure of rights attached to equity shares
21st Apr 20207:00 amRNSAGM update
8th Apr 202011:50 amRNSDirector/PDMR Shareholding
2nd Apr 20202:51 pmRNSHolding(s) in Company
1st Apr 20208:13 amRNSDirector Declaration
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.